View in EDS PDF Full Text

Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer.

Saved in:
Bibliographic Details
Title: Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer.
Authors: Hamy AS; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, U932, Immunity and Cancer, Institut Curie, PSL Research University, Paris, France.; Department of Medical Oncology, Institut Curie, Saint-Cloud, France., Derosa L; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Valdelièvre C; Department of Surgery, Institut Curie, Paris, France., Yonekura S; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Opolon P; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Priour M; Informatics Department, Institut Curie, Paris, France., Guerin J; Informatics Department, Institut Curie, Paris, France., Pierga JY; Department of Medical Oncology, Institut Curie, Saint-Cloud, France., Asselain B; Biostatistics Department, Institut Curie, Paris, France., De Croze D; Tumor Biology, Institut Curie, Paris, France., Pinheiro A; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, U932, Immunity and Cancer, Institut Curie, PSL Research University, Paris, France., Lae M; Tumor Biology, Institut Curie, Paris, France., Talagrand LS; Department of Surgery, Institut Curie, Paris, France., Laas E; Department of Surgery, Institut Curie, Paris, France., Darrigues L; Department of Surgery, Institut Curie, Paris, France., Grandal B; Department of Surgery, Institut Curie, Paris, France., Marangoni E; Preclinical investigation laboratory, Translational Research Department, Institut Curie, PSL Research University, Paris., Montaudon E; Preclinical investigation laboratory, Translational Research Department, Institut Curie, PSL Research University, Paris., Kroemer G; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.; Cell Biology and Metabolomics platforms, Villejuif, France.; INSERM, Paris, France.; Sorbonne Paris Cité, Université Paris Descartes, Paris, France.; Université Pierre et Marie Curie, Paris, France.; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden., Zitvogel L; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Gustave Roussy and Institut Curie, France., Reyal F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, U932, Immunity and Cancer, Institut Curie, PSL Research University, Paris, France.; Department of Surgery, Institut Curie, Paris, France.; Sorbonne Paris Cité, Université Paris Descartes, Paris, France.
Source: Oncoimmunology [Oncoimmunology] 2019 Nov 14; Vol. 9 (1), pp. 1677427. Date of Electronic Publication: 2019 Nov 14 (Print Publication: 2020).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32002287
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hamy+AS%22">Hamy AS</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, U932, Immunity and Cancer, Institut Curie, PSL Research University, Paris, France.; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.<br /><searchLink fieldCode="AU" term="%22Derosa+L%22">Derosa L</searchLink>; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Valdelièvre+C%22">Valdelièvre C</searchLink>; Department of Surgery, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Yonekura+S%22">Yonekura S</searchLink>; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Opolon+P%22">Opolon P</searchLink>; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Priour+M%22">Priour M</searchLink>; Informatics Department, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Guerin+J%22">Guerin J</searchLink>; Informatics Department, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Pierga+JY%22">Pierga JY</searchLink>; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.<br /><searchLink fieldCode="AU" term="%22Asselain+B%22">Asselain B</searchLink>; Biostatistics Department, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22De+Croze+D%22">De Croze D</searchLink>; Tumor Biology, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Pinheiro+A%22">Pinheiro A</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, U932, Immunity and Cancer, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lae+M%22">Lae M</searchLink>; Tumor Biology, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Talagrand+LS%22">Talagrand LS</searchLink>; Department of Surgery, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Laas+E%22">Laas E</searchLink>; Department of Surgery, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Darrigues+L%22">Darrigues L</searchLink>; Department of Surgery, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Grandal+B%22">Grandal B</searchLink>; Department of Surgery, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Marangoni+E%22">Marangoni E</searchLink>; Preclinical investigation laboratory, Translational Research Department, Institut Curie, PSL Research University, Paris.<br /><searchLink fieldCode="AU" term="%22Montaudon+E%22">Montaudon E</searchLink>; Preclinical investigation laboratory, Translational Research Department, Institut Curie, PSL Research University, Paris.<br /><searchLink fieldCode="AU" term="%22Kroemer+G%22">Kroemer G</searchLink>; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.; Cell Biology and Metabolomics platforms, Villejuif, France.; INSERM, Paris, France.; Sorbonne Paris Cité, Université Paris Descartes, Paris, France.; Université Pierre et Marie Curie, Paris, France.; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Zitvogel+L%22">Zitvogel L</searchLink>; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Gustave Roussy and Institut Curie, France.<br /><searchLink fieldCode="AU" term="%22Reyal+F%22">Reyal F</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, U932, Immunity and Cancer, Institut Curie, PSL Research University, Paris, France.; Department of Surgery, Institut Curie, Paris, France.; Sorbonne Paris Cité, Université Paris Descartes, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2019 Nov 14; Vol. 9 (1), pp. 1677427. <i>Date of Electronic Publication: </i>2019 Nov 14 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32002287
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2019.1677427
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1677427
    Titles:
      – TitleFull: Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hamy AS
      – PersonEntity:
          Name:
            NameFull: Derosa L
      – PersonEntity:
          Name:
            NameFull: Valdelièvre C
      – PersonEntity:
          Name:
            NameFull: Yonekura S
      – PersonEntity:
          Name:
            NameFull: Opolon P
      – PersonEntity:
          Name:
            NameFull: Priour M
      – PersonEntity:
          Name:
            NameFull: Guerin J
      – PersonEntity:
          Name:
            NameFull: Pierga JY
      – PersonEntity:
          Name:
            NameFull: Asselain B
      – PersonEntity:
          Name:
            NameFull: De Croze D
      – PersonEntity:
          Name:
            NameFull: Pinheiro A
      – PersonEntity:
          Name:
            NameFull: Lae M
      – PersonEntity:
          Name:
            NameFull: Talagrand LS
      – PersonEntity:
          Name:
            NameFull: Laas E
      – PersonEntity:
          Name:
            NameFull: Darrigues L
      – PersonEntity:
          Name:
            NameFull: Grandal B
      – PersonEntity:
          Name:
            NameFull: Marangoni E
      – PersonEntity:
          Name:
            NameFull: Montaudon E
      – PersonEntity:
          Name:
            NameFull: Kroemer G
      – PersonEntity:
          Name:
            NameFull: Zitvogel L
      – PersonEntity:
          Name:
            NameFull: Reyal F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 11
              Text: 2019 Nov 14
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 2162-4011
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1